Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Chemical Computing Group
Acquired Company
Simulations Plus
Montreal
LancasterBiotechnologyDescription
Chemical Computing Group has completed the acquisition of Simulations Plus, Inc. for USD 376.8 million, making it a wholly owned subsidiary. Each eligible shareholder received USD 18.50 per share as part of the merger. This acquisition marks the end of Simulations Plus's public-market status as it transitions to private ownership.
Fundz sees it the moment Chemical Computing Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Simulations Plus?
Simulations Plus was acquired by Chemical Computing Group, based in Montreal. The deal was reported on October 16, 2026. Chemical Computing Group is an established company focusing on molecular modeling and drug discovery software. It provides tools used in various sectors such as pharmaceuticals and biotechnology. Chemical Computing Group is privately held and operates in Biotechnology.
When did Chemical Computing Group acquire Simulations Plus?
Chemical Computing Group's acquisition of Simulations Plus was reported on October 16, 2026. Chemical Computing Group has completed the acquisition of Simulations Plus, Inc. for USD 376.8 million, making it a wholly owned subsidiary. Each eligible shareholder received USD 18.50 per share as part of the merger. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Simulations Plus do?
Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. It is publicly traded (SLP), and is based in Lancaster.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.